1. Home
  2. MSW vs CNTB Comparison

MSW vs CNTB Comparison

Compare MSW & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSW
  • CNTB
  • Stock Information
  • Founded
  • MSW 2012
  • CNTB 2012
  • Country
  • MSW Hong Kong
  • CNTB United States
  • Employees
  • MSW N/A
  • CNTB N/A
  • Industry
  • MSW
  • CNTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MSW
  • CNTB Health Care
  • Exchange
  • MSW NYSE
  • CNTB Nasdaq
  • Market Cap
  • MSW N/A
  • CNTB 55.2M
  • IPO Year
  • MSW 2024
  • CNTB 2021
  • Fundamental
  • Price
  • MSW $3.59
  • CNTB $0.69
  • Analyst Decision
  • MSW
  • CNTB Strong Buy
  • Analyst Count
  • MSW 0
  • CNTB 1
  • Target Price
  • MSW N/A
  • CNTB $8.00
  • AVG Volume (30 Days)
  • MSW 64.5K
  • CNTB 17.3K
  • Earning Date
  • MSW 05-25-2025
  • CNTB 03-31-2025
  • Dividend Yield
  • MSW N/A
  • CNTB N/A
  • EPS Growth
  • MSW 18.78
  • CNTB N/A
  • EPS
  • MSW 0.20
  • CNTB N/A
  • Revenue
  • MSW $31,769,612.00
  • CNTB $26,033,000.00
  • Revenue This Year
  • MSW N/A
  • CNTB $997.61
  • Revenue Next Year
  • MSW N/A
  • CNTB N/A
  • P/E Ratio
  • MSW $17.66
  • CNTB N/A
  • Revenue Growth
  • MSW 30.91
  • CNTB N/A
  • 52 Week Low
  • MSW $2.12
  • CNTB $0.55
  • 52 Week High
  • MSW $10.58
  • CNTB $2.66
  • Technical
  • Relative Strength Index (RSI)
  • MSW N/A
  • CNTB 29.72
  • Support Level
  • MSW N/A
  • CNTB $0.80
  • Resistance Level
  • MSW N/A
  • CNTB $0.84
  • Average True Range (ATR)
  • MSW 0.00
  • CNTB 0.06
  • MACD
  • MSW 0.00
  • CNTB -0.01
  • Stochastic Oscillator
  • MSW 0.00
  • CNTB 0.30

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: